Randomized controlled trial of varenicline to treat tobacco and cannabis co-use

Sponsor:

National Cancer Institute

Sponsor Study ID:

R01CA290842

CTO #:

104066

NCT Number:

NCT06883162

Phase:

IV

Protocol Type:

Prevention

Age Group:

Adults

Disease Sites:

Study Objectives:

Evaluate rates of 7-day biochemically confirmed point prevalence abstinence (PPA) from cigarettes at the 12-week end of treatment (EOT) visit comparing varenicline + psychosocial intervention to the placebo + psychosocial intervention participants.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)